Breast Cancer Clinical Trial
A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation
The purpose of this study is to refine the use of an affect-regulated exercise prescription for use with survivors of breast cancer.
Within 5 years of completing curative treatment (surgery, chemotherapy, and radiation) for stage 0-III breast cancer
<60 minsweek moderate-vigorous physical activity with no major changes for the past 6-months
Own an Android or iPhone smartphone and willing to use the smartphone to complete app-based surveys during assessment periods
Willing to wear the ActiGraph monitor during assessment periods
Access to internet to complete REDCap survey assessments
Non-English speaking/not able to read English
Evidence of major contraindications for exercise (informed by the 2020 Physical Activity Readiness-Questionnaire (PAR-Q)+)
History of severe mental illness or currently taking mood stabilizing medications (antipsychotics, anticonvulsants, or lithium)
Evidence of moderate-severe depressive symptoms (indicated by a score ≥10 on Patient Health Questionnaire-8)
Evidence of moderate-severe cognitive impairment (indicated by a score < 3 on a 6-item cognitive screener)
Evidence of clinically significant substance use as indicated by a score of ≥2 on the CAGE-AID screener
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Lebanon New Hampshire, 03756, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.